CVS Caremark settles with FTC; PBM will advance transparency and affordability
The settlement resolves all outstanding FTC litigation and investigations related to CVS Health.
The settlement resolves all outstanding FTC litigation and investigations related to CVS Health.
The lineup showcases science and technologies shaping the future of dietary supplements and functional foods.
The winners offer a forecast of the beauty market's most impactful solutions for the months ahead, across every sector from supply chain to finished product.
The integration is designed to support medication adherence and increase access, especially for patients in pharmacy deserts.
Break the Rules is rooted in a simple consumer truth: beauty advice can often feel like a set of rigid rules.
The association seeks stronger beneficiary access, patient choice, competition, transparency, accountability, and long-term value for taxpayers.
David Pinto examines some of the possible changes the NACDS Annual will have in 2027.
Former Kellanova executive brings more than 35 years of experience building strategic partnerships across the retail industry.
Over 40% of Americans say inflation has caused them to forgo or put off medical care within the past year, a survey from eHealth has found..
"Affordability is a concern for families and a top priority for retailers as we enter the back-to-school season."
More than 50 AI-enabled exhibitors are set for the 2026 NACDS Total Store Expo.
She currently serves as Vice President, Enterprise Quality Governance – Pharmacy & Pharmacovigilance at Cencora.
“CRN continues to attract companies that are committed to advancing science, quality, and responsible innovation throughout the dietary supplement supply chain,” said Steve Mister, president and CEO of CRN.
New offering combines prescription savings with interest-free payments to improve adherence and reduce employer healthcare costs.
The goal is to improve early detection, monitor disease progression, enhance clinical trial enrollment, and advance precision medicine for neurodegenerative diseases.